COMMUNIQUÉS West-GlobeNewswire

BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update
12/05/2025
Presentation at IO 360° conference showed early efficacy for Plinabulin combinations in metastatic NSCLC and Hodgkin lymphoma resistant to PD‑1/L1 therapy SEED’s first‑in‑class RBM39 degrader, reported at AACR 2025 for [...]
ZyVersa Therapeutics Reports First Quarter 2025 Financial Results and Highlights Pipeline Progress
12/05/2025
KEY HIGHLIGHTS First patient expected to start therapy by end of Q2-2025 in Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator TM VAR 200 in patients with diabetic kidney disease (DKD). Obesity- [...]
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/05/2025
PHILADELPHIA, May 12, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid [...]
New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism
12/05/2025
COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment with TransCon PTH ( [...]
Quipt Home Medical Reports Fiscal Second Quarter 2025 Results
12/05/2025
Posts Strong Adjusted EBITDA of 23.3% of Revenue CINCINNATI, May 12, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“ Quipt ” or the “ Company ”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment [...]
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/05/2025
BEDFORD, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention [...]
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
12/05/2025
Hopewell, New Jersey, May 12, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing [...]
Scientific Industries to Host First Quarter Fiscal Year 2025 Financial Results Investor Call on May 14, 2025
12/05/2025
Investor Call to be held at 11:00 AM Eastern Time BOHEMIA, N.Y., May 12, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified [...]
ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
13/05/2025
PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, [...]
Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance
13/05/2025
Fort Mill, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology [...]
IBA SA – NOTIFICATION TRANSPARENCE
12/05/2025
(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 12 mai 2025, 18:00 Résumé de la notification IBA (Ion Beam Applications SA), le [...]
IBA – TRANSPARENCY NOTIFICATION
12/05/2025
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, May 12 th , 2025 06:00 PM Summary of the notification IBA (Ion Beam Applications), the world leader in [...]
Fagron shareholders approve all voting items AGM
12/05/2025
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 12 May 2025 – 7PM CET Fagron shareholders approve all voting items AGM Fagron, the leading global player in pharmaceutical compounding, held its [...]
IBA – ACQUISITION D’ACTIONS PROPRES
12/05/2025
Publication immédiate – 12 mai 2025 Louvain-la-Neuve, Belgique, 12 mai 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam [...]
IBA – ACQUISITION OF OWN SHARES
12/05/2025
Immediate Release – May 12 th , 2025 Louvain-la-Neuve, Belgium, May 12 th , 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam [...]
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
12/05/2025
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of [...]
Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision
12/05/2025
Webinar to Feature CEO Janet Huffman, Chief Clinical Officer Dr. Frank Peacock, and Dr. James Kelly, Followed by Live Q&A SARASOTA, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a [...]
Nurses Speak Out on Burnout, Balance, and the Future of the Profession in New Survey
12/05/2025
Heart of Healthcare Under Pressure: 1 in 3 Nurses Near Retirement as Continued Volatility Persists DALLAS, May 12, 2025 (GLOBE NEWSWIRE) -- While 75% of nurses report being satisfied with their career choice, many still [...]
Speakers, Panels and Networking Opportunities Announced for Cannabis Means Business in New York
12/05/2025
Cannabis Workforce Initiative Job Fair, Women in Cannabis Luncheon, and more at the premier cannabis industry trade show and conference, June 4-5 in NYC NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Cannabis Means Business [...]

Pages